Validation Testing in Thorough QT/QTc Clinical Trials

By Tsong Yi   Zhong Jinglin   Chen Wen Jen  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 3, 2008-05 ,pp. : 529-541

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Joint Modeling of Drug and Positive Control Effects to Estimate Sample Size and Power in Crossover “Thorough” QT/QTc Studies

By Hosmane Balakrishna   Locke Charles   Chiu Yi-Lin  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 871-880

Taylor & Francis Ltd

Access to resources Recommend Favorite

Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study

By Morganroth Joel   Gretler Daniel D   Hollenbach Stanley J   Lambing Joseph L   Sinha Uma  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 6, 2015-11 ,pp. : 454-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation: A Thorough QTc Study

By >  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 599-611

Adis International

Access to resources Recommend Favorite